2. GPCR/G Protein Neuronal Signaling Metabolic Enzyme/Protease PI3K/Akt/mTOR MAPK/ERK Pathway Stem Cell/Wnt
  3. 5-HT Receptor PGC-1α Akt PI3K Ras MEK ERK
  4. MARY1

MARY1 is a selective 5-HT2BR antagonist with an IC50 of 380 nM and a Ki of 764 nM (human 5-HT2BR). MARY1 induces renal mitochondrial biogenesis (MB) and enhances renal mitochondrial function by increasing mitochondrial respiratory capacity, mitochondrial protein levels, and mitochondrial number in renal proximal tubular cells (RPTCs). MARY1 induces MB through 5-HT2BR and dual PI3K/AKT and RAS/MEK/ERK cell signaling pathways in RPTCs. MARY1 induces mesonephric cortical MB in mice and rats and enhances renal mitochondrial function. MARY1 can be used to study renal diseases associated with metabolic and mitochondrial dysfunction[1].

For research use only. We do not sell to patients.

MARY1 Chemical Structure

MARY1 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

MARY1 Related Antibodies

Top Publications Citing Use of Products

View All 5-HT Receptor Isoform Specific Products:

View All Isoforms
5-HT Receptor 5-HT1 Receptor 5-HT2 Receptor 5-HT3 Receptor 5-HT4 Receptor 5-HT5 Receptor 5-HT6 Receptor 5-HT7 Receptor

View All Akt Isoform Specific Products:

View All Isoforms
Akt Akt1 Akt2 Akt3

View All PI3K Isoform Specific Products:

View All Isoforms
PI3Kα PI3Kβ PI3Kγ PI3Kδ PI3KC2α PI3KC2β PI3KC2γ Vps34 PI3K PI3KC3 p120γ

View All Ras Isoform Specific Products:

View All Isoforms
K-Ras H-Ras N-Ras Ras

View All MEK Isoform Specific Products:

View All Isoforms
MEK1 MEK2 MEK5 MEK

View All ERK Isoform Specific Products:

View All Isoforms
ERK ERK1 ERK2 ERK5 ERK8

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

MARY1 is a selective 5-HT2BR antagonist with an IC50 of 380 nM and a Ki of 764 nM (human 5-HT2BR). MARY1 induces renal mitochondrial biogenesis (MB) and enhances renal mitochondrial function by increasing mitochondrial respiratory capacity, mitochondrial protein levels, and mitochondrial number in renal proximal tubular cells (RPTCs). MARY1 induces MB through 5-HT2BR and dual PI3K/AKT and RAS/MEK/ERK cell signaling pathways in RPTCs. MARY1 induces mesonephric cortical MB in mice and rats and enhances renal mitochondrial function. MARY1 can be used to study renal diseases associated with metabolic and mitochondrial dysfunction[1].

IC50 & Target[1]

5-HT2B Receptor

380 nM (IC50)

human 5-HT2B Receptor

761 nM (Ki)

In Vitro

MARY1 binds with moderate affinity to 5-HT2BR, with no significant binding to 5-HT2A/2C receptors[1].

MARY1 (1 nM-1 μM, 24 h) increase maximal mitochondrial respiration in RPTCs[1].

MARY1 (1 nM, 24 h) enhances cellular mitochondrial maximal respiration, upregulates key genes responsible for mitochondrial bioenergetics, and increases the number of mitochondria in RPTCs[1].

MARY1 increases PGC-1α expression in RPTCs treated with scRNA but not in those treated with siRNA[1].

MARY1 (1 nM, 20 min) induces MB through 5-HT2BR and dual PI3K/AKT and RAS/MEK/ERK cell signaling pathways in RPTCs[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

MARY1 Related Antibodies

Western Blot Analysis[1]

Cell Line: RPTCs
Concentration: 1 nM
Incubation Time: 24 h
Result: Increased the protein levels of mitochondrial-specific genes in RPTCs, including carnitine palmitoyltransferase 1A (CPT1A), acyl-CoA synthetase medium-chain family member 2A (ACSM2A), and NADH dehydrogenase [ubiquinone] 1β subcomplex subunit 8 (NDUFB8).

Western Blot Analysis[1]

Cell Line: RPTCs
Concentration: 1 nM
Incubation Time: 20 min
Result: Increased pAKT (S473) and pFOXO1 (S256) .
Activated RAS GTPase and activated phosphorylation of extracellular signal-regulated kinase (pERK) at the threonine 202/tyrosine 204 (T202/Y204) position.
In Vivo

MARY1 (0.3 mg/kg, i.p.,once) induces MB in the renal cortex in male C57BL/6NCrl mice[1].

MARY1 (0.15 mg / kg, 0.3 mg / kg, i.p., once) induces MB in the renal cortex in Male SD rats[1].

MARY1 (0.15-15 mg/kg, i.p., once a day, 4 weeks) does not cause any death or organ and weight abnormalities in male SD rats[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male C57BL/6NCrl mice 8 weeks of age and weighing ∼20–25 g[1]
Dosage: 0.3 mg/kg
Administration: i.p.,once
Result: Increased PGC-1α and sirtuin 1 (SIRT1) mRNA, and mtDNA content (DLOOP and mtND1) in the renal cortex, with no effect on mitochondrial transcription factor A.
Upregulated nuclear (3.46-fold), but not cytosolic PGC-1α in the renal cortex.
Increased ACSM2A (1.75-fold), NDUFB8 (1.52-fold), and stearoyl-CoA desaturase 1 (SCD1; 1.65-fold) proteins.
Increased complex I (NDUFB8) and II (SDHB) proteins of the mitochondrial electron transport chain, with no changes in complexes III (UQCRC2), IV (MTCO1), or V (ATP5A)
Increased mitochondrial fission proteins mitochondrial fission factor (Mff; 1.79-fold) and dynamin-related protein 1 (Drp1; 2.01-fold) in the mouse renal cortex, but not mitochondrial fusion proteins mitofusin 1 (MFN1) and 2 (MFN2), and did not alter TFAM protein levels.
Animal Model: Male SD rats(weighing 250–300 g) [1]
Dosage: 0.15 mg / kg, 0.3 mg / kg
Administration: i.p., once
Result: Increased PGC-1α protein levels in the renal cortex at both doses.
Animal Model: Male SD rats(weighing 250–300 g) [1]
Dosage: 0.15 mg / kg, 1.5mg / kg, 15 mg / kg
Administration: i.p., once a day, 4 weeks
Result: Did not cause any death or organ and weight abnormalities.
Molecular Weight

378.35

Formula

C18H17F3N4O2
SMILES

FC1=C(C(F)=CC(F)=C1)C(NC2=NC(C(N3CCN(CC3)C)=O)=CC=C2)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

MARY1 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

MARY1MARY 1MARY-15-HT ReceptorPGC-1αAktPI3KRasMEKERKSerotonin Receptor5-hydroxytryptamine ReceptorPPARγ coactivator-1αPKBProtein kinase BPhosphoinositide 3-kinaseMitogen-activated protein kinase kinaseMAPKKMAP2KExtracellular signal regulated kinasesAntagonistKidney diseaseRPTCs5-HT2BRPI3K/AKTRAS/MEK/ERKInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
MARY1
Cat. No.:
HY-174306
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.